1. Busse, W. W., and Lemanske, R. F., Jr. (2001) Asthma. N. Engl. J. Med. 344, 350–362
2. Mickleborough, T. D., Lindley, M. R., Ionescu, A. A., and Fly, A. D. (2006) Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 129, 39–49
3. Li, J., Xun, P., Zamora, D., Sood, A., Liu, K., Daviglus, M., Iribarren, C., Jacobs, D., Jr., Shikany, J. M., and He, K. (2013) Intakes of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study. Am. J. Clin. Nutr. 97, 173–178
4. Horrobin, D. F. (1987) Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both? Med. Hypotheses 22, 421–428
5. Barros, R., Moreira, A., Fonseca, J., Delgado, L., Castel-Branco, M. G., Haahtela, T., Lopes, C., and Moreira, P. (2011) Dietary intake of a-linolenic acid and low ratio of n-6:n-3 PUFA are associated with decreased exhaled NO and improved asthma control. Br. J. Nutr. 106, 441–450
6. Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., and Gronert, K. (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and trans- cellular processing. J. Exp. Med. 192, 1197–1204
7. Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., and Moussignac, R. L. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initi- ated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025–1037
8. Gilroy, D. W., Lawrence, T., Perretti, M., and Rossi, A. G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401–416
9. Schwab, J. M., Chiang, N., Arita, M., and Serhan, C. N. (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869–874
10. Aoki, H., Hisada, T., Ishizuka, T., Utsugi, M., Kawata, T., Shimizu, Y., Okajima, F., Dobashi, K., and Mori, M. (2008) Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem. Biophys. Res. Commun. 367, 509–515
11. Aoki, H., Hisada, T., Ishizuka, T., Utsugi, M., Ono, A., Koga, Y., Sunaga, N., Nakakura, T., Okajima, F., Dobashi, K., and Mori, M. (2010) Protective effect of resolvin E1 on the development of asthmatic airway inflammation. Biochem. Biophys. Res. Commun. 400, 128–133
12. Haworth, O., Cernadas, M., Yang, R., Serhan, C. N., and Levy, B. D. (2008) Resolvin E1 regulates interleukin 23, interferon-g and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 9, 873–879
13. Haworth, O., Cernadas, M., and Levy, B. D. (2011) NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation. J. Immunol. 186, 6129–6135
14. Isobe, Y., Arita, M., Matsueda, S., Iwamoto, R., Fujihara, T., Nakanishi, H., Taguchi, R., Masuda, K., Sasaki, K., Urabe, D., Inoue, M., and Arai, H. (2012) Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid. J. Biol. Chem. 287, 10525–10534
15. Gold, M. J., Antignano, F., Halim, T. Y., Hirota, J. A., Blanchet, M. R., Zaph, C., Takei, F., and McNagny, K. M. (2014) Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J. Allergy Clin. Immunol. 133, 1142–1148
16. Gru¨ nig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., and Corry, D. B. (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282, 2261–2263
17. Mogi, C., Tobo, M., Tomura, H., Murata, N., He, X. D., Sato, K., Kimura, T., Ishizuka, T., Sasaki, T., Sato, T., Kihara, Y., Ishii, S., Harada, A., and Okajima, F. (2009) Involvement of proton-sensing TDAG8 in extracellular acidification-induced inhibition of proin- flammatory cytokine production in peritoneal macrophages. J. Immunol. 182, 3243–3251
18. Shenoy, S. K., and Lefkowitz, R. J. (2005) Receptor-specific ubiquitination of b-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J. Biol. Chem. 280, 15315–15324
19. Kim, J. H., Lee, S. R., Li, L. H., Park, H. J., Park, J. H., Lee, K. Y., Kim, M. K., Shin, B. A., and Choi, S. Y. (2011) High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One 6, e18556
20. Hiroshima, M., Pack, C. G., Kaizu, K., Takahashi, K., Ueda, M., and Sako, Y. (2018) Transient acceleration of epidermal growth factor receptor dynamics produces higher-order signaling clusters. J. Mol. Biol. 430, 1386–1401
21. Kroeze, W. K., Sassano, M. F., Huang, X. P., Lansu, K., McCorvy, J. D., Gigue`re, P. M., Sciaky, N., and Roth, B. L. (2015) PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362–369
22. Dixon, A. S., Schwinn, M. K., Hall, M. P., Zimmerman, K., Otto, P., Lubben, T. H., Butler, B. L., Binkowski, B. F., Machleidt, T., Kirkland, T. A., Wood, M. G., Eggers, C. T., Encell, L. P., and Wood, K. V. (2016) NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells. ACS Chem. Biol. 11, 400–408
23. Yanagawa, M., Hiroshima, M., Togashi, Y., Abe, M., Yamashita, T., Shichida, Y., Murata, M., Ueda, M., and Sako, Y. (2018) Single-molecule diffusion-based estimation of ligand effects on G protein-coupled receptors. Sci. Signal. 11, eaao1917
24. Arita, M., Ohira, T., Sun, Y. P., Elangovan, S., Chiang, N., and Serhan, C. N. (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178, 3912–3917
25. Oh, S. F., Dona, M., Fredman, G., Krishnamoorthy, S., Irimia, D., and Serhan, C. N. (2012) Resolvin E2 formation and impact in inflammation resolution. J. Immunol. 188, 4527–4534
26. Ku¨ hn, H., and O’Donnell, V. B. (2006) Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45, 334–356
27. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., and Cua, D. J. (2005) IL-23 drives a pathogenic T cell population that induces au- toimmune inflammation. J. Exp. Med. 201, 233–240
28. Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., and Oft, M. (2006) IL-23 promotes tumour incidence and growth. Nature 442, 461–465
29. Chan, J. R., Blumenschein, W., Murphy, E., Diveu, C., Wiekowski, M., Abbondanzo, S., Lucian, L., Geissler, R., Brodie, S., Kimball, A. B., Gorman, D. M., Smith, K., de Waal Malefyt, R., Kastelein, R. A., McClanahan, T. K., and Bowman, E. P. (2006) IL-23 stimulates epi- dermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203, 2577–2587
30. Yago, T., Nanke, Y., Kawamoto, M., Furuya, T., Kobashigawa, T., Kamatani, N., and Kotake, S. (2007) IL-23 induces human osteoclas- togenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res. Ther. 9, R96
31. Lewkowich, I. P., Lajoie, S., Clark, J. R., Herman, N. S., Sproles, A. A., and Wills-Karp, M. (2008) Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyper- responsiveness in asthma-susceptible mice. PLoS One 3, e3879
32. Vroman, H., van den Blink, B., and Kool, M. (2015) Mode of dendritic cell activation: the decisive hand in Th2/Th17 cell differentiation. Implications in asthma severity? Immunobiology 220, 254–261
33. Martinez, G. J., Nurieva, R. I., Yang, X. O., and Dong, C. (2008) Regulation and function of proinflammatory TH17 cells. Ann. N. Y. Acad. Sci. 1143, 188–211
34. Pichavant, M., Goya, S., Meyer, E. H., Johnston, R. A., Kim, H. Y., Matangkasombut, P., Zhu, M., Iwakura, Y., Savage, P. B., DeKruyff, R. H., Shore, S. A., and Umetsu, D. T. (2008) Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J. Exp. Med. 205, 385–393
35. Molet, S., Hamid, Q., Davoine, F., Nutku, E., Taha, R., Page´, N., Olivenstein, R., Elias, J., and Chakir, J. (2001) IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to pro- duce cytokines. J. Allergy Clin. Immunol. 108, 430–438
36. Wakashin, H., Hirose, K., Maezawa, Y., Kagami, S., Suto, A., Watanabe, N., Saito, Y., Hatano, M., Tokuhisa, T., Iwakura, Y., Puccetti, P., Iwamoto, I., and Nakajima, H. (2008) IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 178, 1023–1032
37. Peng, J., Yang, X. O., Chang, S. H., Yang, J., and Dong, C. (2010) IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation. Cell Res. 20, 62–71
38. Nakajima, H., and Hirose, K. (2010) Role of IL-23 and Th17 cells in airway inflammation in asthma. Immune Netw. 10, 1–4
39. Nakamura, M., and Shimizu, T. (2011) Leukotriene receptors. Chem. Rev. 111, 6231–6298
40. Okuno, T., Ago, H., Terawaki, K., Miyano, M., Shimizu, T., and Yokomizo, T. (2003) Helix 8 of the leukotriene B4 receptor is required for the conformational change to the low affinity state after G-protein activation. J. Biol. Chem. 278, 41500–41509
41. Nakanishi, Y., Tan, M., Ichiki, T., Inoue, A., Yoshihara, J. I., Maekawa, N., Takenoshita, I., Yanagida, K., Yamahira, S., Yamaguchi, S., Aoki, J., Nagamune, T., Yokomizo, T., Shimizu, T., and Nakamura, M. (2018) Stepwise phosphorylation of leukotriene B4 receptor 1 defines cellular responses to leukotriene B4. Sci. Signal. 11, eaao5390